ESR1 and neoplasm: Despite that aspects of the molecular estrogen receptor-p53 associations are not completely understood, it is evident that the p53 pathway is regulated by estrogen and adjusting ER activity with ER-subtype specific ligands may control p53-dependent tumor suppressor function.